HM3A, a Belgium-based consultancy firm that specialises in market access, has joined the Vivactis Group. This will further strengthen the services the group offers the healthcare sector in Europe, Mexico and the United States.
With more than 10 years of experience in the Benelux region, HM3A founders highlight that, with the European Medicines Agency moving to Amsterdam, it is a great time to contribute all of the firm’s experience in the European market, both with drugs and medical devices.
For Vivactis, this new addition to the group will reinforce its ability to build and implement effective, innovative programmes and consistent strategies for its clients.
